Last reviewed · How we verify

Mavik — Competitive Intelligence Brief

Mavik (Mavik) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Cardiovascular.

marketed Angiotensin-converting enzyme Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Mavik (Mavik) — Dr. Reddy's Laboratories Limited.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Mavik TARGET Mavik Dr. Reddy's Laboratories Limited marketed Angiotensin-converting enzyme
Renormax SPIRAPRIL HYDROCHLORIDE marketed spirapril Angiotensin-converting enzyme 1994-01-01
Aceon PERINDOPRIL ARGININE Symplmed Pharms Llc marketed Angiotensin Converting Enzyme Inhibitor Angiotensin-converting enzyme 1993-01-01
Monopril FOSINOPRIL marketed Angiotensin Converting Enzyme Inhibitor Angiotensin-converting enzyme 1991-01-01
Accupril QUINAPRIL Pfizer marketed Angiotensin Converting Enzyme Inhibitor Angiotensin-converting enzyme 1991-01-01
Altace RAMIPRIL King Pfizer marketed Angiotensin Converting Enzyme Inhibitor [EPC] Angiotensin-converting enzyme 1991-01-01
Lotensin BENAZEPRIL Validus Pharms marketed Angiotensin Converting Enzyme Inhibitor Angiotensin-converting enzyme 1991-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Mavik — Competitive Intelligence Brief. https://druglandscape.com/ci/mavik. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: